Loading

Commentary Open Access
Volume 4 | Issue 1 | DOI: https://doi.org/10.46439/gastro.4.026

Advancing liver disease treatment: The promise of phytotherapy and hepatic stellate cell modulation

  • 1Division of Food Safety, Indian Council of Medical Research - National Institute of Nutrition, Beside Tarnaka Metro Station, Jamai-Osmania PO, Hyderabad-500 007, INDIA
+ Affiliations - Affiliations

Corresponding Author

Sathish Kumar Mungamuri, sathish.mungamuri@icmr.gov.in; mungamurisk@gmail.com

Received Date: June 02, 2025

Accepted Date: September 04, 2025

Abstract

Liver diseases, such as cirrhosis and hepatocellular carcinoma (HCC), significantly contribute to global mortality rates, with increasing cases associated with hepatitis viruses, alcohol-related liver disease, and non-alcoholic fatty liver disease (NAFLD). Conventional treatments often encounter limitations due to side effects, high costs, and incomplete efficacy, highlighting the need for alternative therapeutic strategies. Phytotherapy, which utilizes bioactive plant compounds (e.g., flavonoids, polyphenols, and alkaloids), offers a promising approach due to its hepatoprotective, antioxidant, anti-inflammatory, and anti-fibrotic properties. These multi-targeted actions effectively address oxidative stress, inflammation, and fibrosis while promoting liver regeneration. A critical aspect of liver disease pathogenesis is the activation of hepatic stellate cells (HSCs), which drive fibrosis through the deposition of extracellular matrix. Targeting HSCs-by inhibiting the TGF-β/Smad and PI3K/Akt pathways—has shown promise in reversing fibrosis in preclinical studies. Recent advancements highlight the synergy between phytotherapy and HSC-targeted strategies, with traditional herbal formulations proving effective in suppressing HSC activation and alleviating liver damage. Despite these encouraging results, challenges persist, including the standardization of herbal extracts, clinical validation, and a deeper understanding of HSC heterogeneity. Emerging technologies, such as CRISPR-Cas9 and nanoparticle delivery systems, may enhance precision in HSC modulation. The integration of phytotherapy with conventional medicine has the potential to revolutionize liver disease management, especially in resource-limited settings. Continued research and robust clinical trials are crucial to translating these findings into safe and effective therapies, offering hope for reducing the global burden of liver diseases.

Keywords

Liver disease, Phytotherapy, Hepatic Stellate Cells, Fibrosis, Hepatoprotective, Anti-inflammatory, Oxidative stress, Traditional medicine

Author Information X